Constitutive GLI1 expression in chondrosarcoma is regulated by major vault protein via mTOR/S6K1 signaling cascade

被引:19
|
作者
Wang, Wei [1 ,2 ]
Yan, Taiqiang [1 ,2 ]
Guo, Wei [1 ,2 ]
Niu, Jianfang [1 ,2 ]
Zhao, Zhiqing [1 ,2 ]
Sun, Kunkun [3 ]
Zhang, Hongliang [1 ,2 ]
Yu, Yiyang [1 ,2 ]
Ren, Tingting [1 ,2 ]
机构
[1] Peking Univ Peoples Hosp, Musculoskeletal Tumor Ctr, Beijing, Peoples R China
[2] Beijing Key Lab Musculoskeletal Tumor, Beijing, Peoples R China
[3] Peking Univ Peoples Hosp, Dept Pathol, Beijing, Peoples R China
来源
CELL DEATH AND DIFFERENTIATION | 2021年 / 28卷 / 07期
基金
中国国家自然科学基金;
关键词
CELL-LINE; GENOMIC ANALYSIS; HEDGEHOG; PATHWAYS; SUPPRESSOR; STRATEGIES; RESISTANCE; CROSSTALK; BONE;
D O I
10.1038/s41418-021-00749-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hedgehog signaling plays a pivotal role in embryonic pattern formation and diverse aspects of the postnatal biological process. Perturbation of the hedgehog pathway and overexpression of GLI1, a downstream transcription factor in the hedgehog pathway, are highly relevant to several malignancies including chondrosarcoma (CS). We previously found that knocking down expression of GLI1 attenuates the disrupted Indian hedgehog (IHH) signal pathway and suppresses cell survival in human CS cells. However, the underlying mechanisms regulating the expression of GLI1 are still unknown. Here, we demonstrated the implication of GLI1 in SMO-independent pathways in CS cells. A GLI1 binding protein, major vault protein (MVP), was identified using the affinity purification method. MVP promoted the nuclear transport and stabilization of GLI1 by compromising the binding affinity of GLI1 with suppressor of fused homolog (SUFU) and increased GLI1 expression via mTOR/S6K1 signaling cascade. Functionally, knockdown of MVP suppressed cell growth and induced apoptosis. Simultaneous inhibition of MVP and GLI1 strongly inhibits the growth of CS in vitro and in vivo. Moreover, IHC results showed that MVP, GLI1, and P-p70S6K1 were highly expressed and positively correlated with each other in 71 human CS tissues. Overall, our findings revealed a novel regulating mechanism for HH-independent GLI1 expression and provide a rationale for combination therapy in patients with advanced CS.
引用
收藏
页码:2221 / 2237
页数:17
相关论文
共 50 条
  • [21] Cryptotanshinone Prevents the Binding of S6K1 to mTOR/Raptor Leading to the Suppression of mTORC1-S6K1 Signaling Activity and Neoplastic Cell Transformation
    Jeoung, Nam Ho
    Jeong, Ji Yun
    Kang, Bong Seok
    JOURNAL OF CANCER PREVENTION, 2021, 26 (02) : 145 - 152
  • [22] Eudesmin impairs adipogenic differentiation via inhibition of S6K1 signaling pathway
    Nam, Ki Hong
    Yi, Sang Ah
    Lee, Jaecheol
    Lee, Min Gyu
    Park, Jee Hun
    Oh, Hwamok
    Lee, Jieun
    Park, Jong Woo
    Han, Jeung-Whan
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2018, 505 (04) : 1148 - 1153
  • [23] Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
    Perez-Tenorio, Gizeh
    Karlsson, Elin
    Waltersson, Marie Ahnstrom
    Olsson, Birgit
    Holmlund, Birgitta
    Nordenskjold, Bo
    Fornander, Tommy
    Skoog, Lambert
    Stal, Olle
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (03) : 713 - 723
  • [24] Distinct Roles of mTOR Targets S6K1 and S6K2 in Breast Cancer
    Sridharan, Savitha
    Basu, Alakananda
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (04)
  • [25] Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
    Gizeh Pérez-Tenorio
    Elin Karlsson
    Marie Ahnström Waltersson
    Birgit Olsson
    Birgitta Holmlund
    Bo Nordenskjöld
    Tommy Fornander
    Lambert Skoog
    Olle Stål
    Breast Cancer Research and Treatment, 2011, 128 : 713 - 723
  • [26] Estrogen receptor α is a target of mTOR/S6K1 signaling in control of breast cancer cell proliferation.
    Holz, M. K.
    Digilova, A.
    Yamnik, R.
    Davis, D.
    Murphy, C.
    Brodt, N.
    CANCER RESEARCH, 2009, 69 (02) : 269S - 269S
  • [27] Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer
    Shao, Xinyu
    Cheng, Zhengwu
    Xu, Menglin
    Mao, Jiading
    Wang, Junfeng
    Zhou, Chunli
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2019, 19 (11) : 1359 - 1367
  • [28] Co-regulatory relationship between estrogen receptor alpha and the mTOR/S6K1 signaling pathways
    Holz, Marina K.
    Maruani, D. Myriam
    Seligman, Fannie
    Spiegel, Tirtza
    Harris, Emily
    Shachter, Avielle
    Beren, Faygel
    CANCER RESEARCH, 2011, 71
  • [29] S6K1 and mTOR regulate Rac1-driven platelet activation and aggregation
    Aslan, Joseph E.
    Tormoen, Garth W.
    Loren, Cassandra P.
    Pang, Jiaqing
    McCarty, Owen J. T.
    BLOOD, 2011, 118 (11) : 3129 - 3136
  • [30] Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades
    Kim, Seong Won
    Kim, Sung-Moo
    Bae, Hang
    Nam, Dongwoo
    Lee, Jun-Hee
    Lee, Seok-Geun
    Shim, Bum Sang
    Kim, Sung-Hoon
    Ahn, Kyoo Seok
    Choi, Seung-Hoon
    Sethi, Gautam
    Ahn, Kwang Seok
    PROSTATE, 2013, 73 (03): : 296 - 305